CD-NP: An innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease

Current Heart Failure Reports

Volumn 7, Issue 3, 2010, Pages 93-99

  McKie, Paul M ^a   Sangaralingham, S Jeson ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiorenal; CD NP; Guanylyl cyclase; Heart failure; Hypertension; Kidney; Natriuretic peptide; Natriuretic peptide receptor

Indexed keywords

CD NATRIURETIC PEPTIDE TYPE C; CYCLIC GMP; ENZYME ACTIVATOR; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C; NESIRITIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CONJUGATION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART RIGHT ATRIUM PRESSURE; HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; PULMONARY ARTERY OCCLUSION PRESSURE; REVIEW; SNAKE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CHIMERA; DIURETICS; DRUG DESIGN; ELAPID VENOMS; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KIDNEY; NATRIURETIC PEPTIDE, C-TYPE; PEPTIDES; RECEPTORS, GUANYLATE CYCLASE-COUPLED;

EID: 77955982186     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-010-0016-6     Document Type: Review

References (38)

1. LR Potter S Abbey-Hosch DM Dickey 2006 Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions Endocr Rev 27 47 72 10.1210/er.2005-0014 1:CAS:528:DC%2BD28XitFSit7c%3D 16291870 This comprehensive review provides detailed and up-to-date information regarding the endogenous natriuretic peptides and their receptors
2. T Sudoh N Minamino K Kangawa H Matsuo 1990 C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain Biochem Biophys Res Commun 168 863 870 10.1016/0006-291X(90)92401-K 1:CAS:528:DyaK3cXktFygtbw%3D 2139780
3. CM Wei LL Aarhus VM Miller JC Burnett Jr 1993 Action of C-type natriuretic peptide in isolated canine arteries and veins Am J Physiol 264 H71 H73 1:CAS:528:DyaK3sXhsVSlt7c%3D 8430863
4. H Schweitz P Vigne D Moinier, et al. 1992 A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps) J Biol Chem 267 13928 13932 1:CAS:528:DyaK38Xls1GltLk%3D 1352773
5. JA Schirger DM Heublein HH Chen, et al. 1999 Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure Mayo Clin Proc 74 126 130 10.4065/74.2.126 1:STN:280:DyaK1M7ms1ykug%3D%3D 10069348
6. O Lisy M Jougasaki DM Heublein, et al. 1999 Renal actions of synthetic dendroaspis natriuretic peptide Kidney Int 56 502 508 10.1046/j.1523-1755.1999. 00573.x 1:CAS:528:DyaK1MXltlOhu7g%3D 10432389
7. JC Burnett Jr J Korinek 2008 The tumultuous journey of nesiritide: past, present, and future Circ Heart Fail 1 6 8 10.1161/CIRCHEARTFAILURE.108.776294 1:CAS:528:DC%2BD1cXosFGnsLg%3D 19808264
8. J Korinek G Boerrigter SF Mohammed JC Burnett Jr 2008 Insights into natriuretic peptides in heart failure: an update Curr Heart Fail Rep 5 97 104 10.1007/s11897-008-0016-y 1:CAS:528:DC%2BD1cXhtV2htrbO 18765080
9. SF Mohammed J Korinek HH Chen, et al. 2008 Nesiritide in acute decompensated heart failure: current status and future perspectives Rev Cardiovasc Med 9 151 158 18953274
10. JD Sackner-Bernstein M Kowalski M Fox K Aaronson 2005 Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 1900 1905 10.1001/jama.293.15. 1900 1:CAS:528:DC%2BD2MXjtl2gs7g%3D 15840865
11. RM Witteles D Kao D Christopherson, et al. 2007 Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial J Am Coll Cardiol 50 1835 1840 10.1016/j.jacc.2007.03.071 1:CAS:528:DC%2BD2sXht1GlurzM 17980248
12. CW Yancy H Krum BM Massie, et al. 2008 Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial Circ Heart Fail 1 9 16 10.1161/CIRCHEARTFAILURE.108.767483 1:CAS:528:DC%2BD1cXosFGnsLk%3D 19808265
13. HH Chen TM Sundt DJ Cook, et al. 2007 Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study Circulation 116 Suppl 11 I134 I138 1:CAS:528:DC%2BD2sXpvFWkt7w%3D 17846293
14. RM Mentzer Jr MC Oz RN Sladen, et al. 2007 Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial J Am Coll Cardiol 49 716 726 10.1016/j.jacc.2006.10.048 1:CAS:528:DC%2BD2sXhs1Slt7c%3D 17291938
15. JS Ross J Chen Z Lin, et al. 2010 Recent national trends in readmission rates after heart failure hospitalization Circ Heart Fail 3 97 103 10.1161/CIRCHEARTFAILURE.109.885210 19903931
16. CY Lee HH Chen O Lisy, et al. 2009 Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects J Clin Pharmacol 49 668 673 10.1177/0091270009336233 1:CAS:528:DC%2BD1MXmvVOruro%3D 19395584
17. O Lisy BK Huntley DJ McCormick, et al. 2008 Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP J Am Coll Cardiol 52 60 68 10.1016/j.jacc.2008.02.077 1:CAS:528:DC%2BD1cXnvVGlt7k%3D 18582636 This article is the first published report of CD-NP and examines the in vivo actions of CD-NP with a comparison to BNP in normal canines
18. DM Dickey JC Burnett Jr LR Potter 2008 Novel bifunctional natriuretic peptides as potential therapeutics J Biol Chem 283 35003 35009 10.1074/jbc.M804538200 1:CAS:528:DC%2BD1cXhsVGqt7%2FN 18940797 This article provides a comprehensive assessment of CD-NP binding affinity for the natriuretic peptide receptors
19. CY Lee H Lieu JC Burnett Jr 2009 Designer natriuretic peptides J Investig Med 57 18 21 19158603
20. ML Honing P Smits PJ Morrison, et al. 2001 C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels Hypertension 37 1179 1183 1:CAS:528:DC%2BD3MXjtFCgt7o%3D 11304521
21. RS Wright CM Wei CH Kim, et al. 1996 C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems J Am Coll Cardiol 28 1031 1038 10.1016/S0735-1097(96) 00241-0 1:CAS:528:DyaK28XmsVajsbY%3D 8837586
22. AL Clavell AJ Stingo CM Wei, et al. 1993 C-type natriuretic peptide: a selective cardiovascular peptide Am J Physiol 264 R290 R295 1:CAS:528: DyaK3sXitVGqtbk%3D 8383462
23. AJ Stingo AL Clavell LL Aarhus JC Burnett Jr 1992 Cardiovascular and renal actions of C-type natriuretic peptide Am J Physiol 262 H308 H312 1:CAS:528:DyaK38XhtVSitr0%3D 1310235
24. B Lewko N Endlich W Kriz, et al. 2004 C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress Kidney Int 66 1001 1008 10.1111/j.1523-1755.2004.00848.x 1:CAS:528:DC%2BD2cXnvVCrt7c%3D 15327393
25. A Hobbs P Foster C Prescott, et al. 2004 Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide Circulation 110 1231 1235 10.1161/01.CIR.0000141802.29945.34 1:CAS:528:DC%2BD2cXntFSksL0%3D 15337698
26. RA Rose WR Giles 2008 Natriuretic peptide C receptor signalling in the heart and vasculature J Physiol 586 353 366 10.1113/jphysiol.2007.144253 1:CAS:528:DC%2BD1cXhsFSis7k%3D 18006579
27. T Horio T Tokudome T Maki, et al. 2003 Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts Endocrinology 144 2279 2284 10.1210/en.2003-0128 1:CAS:528:DC%2BD3sXktFehtb8%3D 12746286
28. T Soeki I Kishimoto H Okumura, et al. 2005 C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction J Am Coll Cardiol 45 608 616 10.1016/j.jacc.2004.10.067 1:CAS:528:DC%2BD2MXhtlSmsrw%3D 15708711
29. RS Scotland A Ahluwalia AJ Hobbs 2005 C-type natriuretic peptide in vascular physiology and disease Pharmacol Ther 105 85 93 10.1016/j.pharmthera. 2004.08.011 1:CAS:528:DC%2BD2MXmvFGlsQ%3D%3D 15670620
30. PR Kalra JR Clague AJ Coats, et al. 2009 C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure Clin Sci (Lond) 118 71 77 10.1042/CS20090092 This study, performed in humans, demonstrates CNP production in the kidneys in patients with heart failure is blunted when compared to patients without heart failure
31. DG Johns Z Ao BJ Heidrich, et al. 2007 Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor Biochem Biophys Res Commun 358 145 149 10.1016/j.bbrc.2007.04.079 1:CAS:528:DC%2BD2sXlt1ersL4%3D 17475216
32. G Singh RE Kuc JJ Maguire, et al. 2006 Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure Circ Res 99 183 190 10.1161/01.RES.0000232322.06633.d3 1:CAS:528:DC%2BD28XmvFaltb4%3D 16778132
33. HH Chen JG Lainchbury JC Burnett Jr 2002 Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide dendroaspis natriuretic peptide J Am Coll Cardiol 40 1186 1191 10.1016/S0735-1097(02)02127-7 1:CAS:528:DC%2BD38XnvVygs7k%3D 12354448
34. O Lisy JG Lainchbury H Leskinen JC Burnett Jr 2001 Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure Hypertension 37 1089 1094 1:CAS:528:DC%2BD3MXjtFChsLg%3D 11304508
35. T Ichiki BK Huntley SJ Sangaralingham, et al. 2009 A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen type I production in human cardiac fibroblasts J Card Fail 15 S34 10.1016/j.cardfail. 2009.06.318
36. O Lisy HH Chen J Burnett 2009 Cardiorenal actions of new designer natriuretic peptide CD-NP in experimental heart failure J Am Coll Cardiol 53 A149 10.1016/j.jacc.2008.05.066
37. FL Martin SJ Sangaralingham PM McKie, et al. 2009 Prevention of cardiorenal fibrosis and suppression of proteinuria and aldosterone activation following experimental myocardial infarction with the novel natriuretic peptide CD-NP J Card Fail 15 S3 10.1016/j.cardfail.2009.06.421
38. H Lieu S Goldsmith J Neutal, et al. 2009 Initial observations of intravenous CD-NP, chimeric natriuretic peptide, on renal functions in chronic heart failure patients J Card Fail 15 S77 10.1016/j.cardfail.2009.06.180